Dr. Snyders’ innovation reinforces the cardiac tissue of patients with failing hearts. It is an important portfolio for companies involved in cardiac failure, cardiology, dilated cardiomyopathy, ventricular assist devices, and surgical cardiomyoplasty.
NEW YORK, NY (PRWEB) September 17, 2015
ICAP Patent Brokerage announces for sale patents disclosing the next generation in ventricular assist devices (VAD) for the heart – a measurable, controllable and adjustable viscous cardioplasty jacket for encasing the ventricles of the heart with supportive structure to provide more efficient myocardial energetics and increase the overall physical activity of a patient. This portfolio is available from Dr. Robert V. Snyders as part of the Cardiovascular Patent Auction. The brokerage continues to accept technology submissions for the auction, which will have a bidding deadline of December 10, 2015.
Robert V. Snyders, M.D. has been actively involved for the last 30 years in the design, fabrication and prototype production of cardiovascular devices. He is a graduate from the St. Louis University School of Medicine and has served as a medical officer in Korea for the US Army. See the inventor biography for Dr. Snyders.
“Dr. Snyders’ innovation reinforces the cardiac tissue of patients with failing hearts,” says Dean Becker, CEO of ICAP Patent Brokerage. “It is an important portfolio for companies involved in cardiac failure, cardiology, dilated cardiomyopathy, ventricular assist devices, and surgical cardiomyoplasty.”
Dr. Snyders plans to present these technologies to the public on a live conference call to the market on September 29th, 2015 at 11:00 AM EST. Individuals who wish to listen in or participate anonymously during the call may dial 1-310-971-9099 and are encouraged to submit questions directed to Dr. Snyders before the call by emailing Michelle Tyler below.
Key Characteristics & Benefits
The device includes a long-term viscous silicone fluid filled jacket device (the Viscous Cardioplasty Jacket, or VCJ) for treating late stage heart failure, which device is called a volume reduction and reverse ventricular wall remodeling and reinforcement device. The measurable, controllable and adjustable VCJ encloses the Left and Right ventricular heart walls using the proven engineering principle of stress reduction due to a reduction of the radius of curvature of any fluid-filled body (Law of LaPlace) to enable a more efficient cardiologic pumping activity and thereby improve the patient's heart function and the patient’s quality of life.
See the technical description of the Cardiomyopathy Surgical Heart Assist IP sales offering.
Sample forward or rearward citing companies include Auburn Council, Boston Scientific Corporation, Cardiokinetix Inc., Edwards Lifesciences Corp, Getinge AB, Johnson & Johnson, Kirk Promotions Limited, Mardil Inc California, Myocardiocare, Inc., Colorado, Olympus Corporation, Paracor Medical Inc, and Sentreheart, Inc., California.
To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (650) 741-4117 or via email at michelle(at)icapip(dot)com.
If you would like to sell or auction a patent portfolio, visit our website to make a patent portfolio submission:
Follow us on Twitter (@ICAP_IP) and join our LinkedIn group.
About ICAP Patent Brokerage
ICAP Patent Brokerage is the world's largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.